Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Germing

Showing results (141-150 of 339) with videos related to

Pageof 34
Sort By:
Haematologica|May 19, 2018
Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemiaStefanie Geyh, Manuel Rodríguez-Paredes, Paul Jäger, et al.
Plos Computational Biology|April 26, 2014
Feedback signals in myelodysplastic syndromes: increased self-renewal of the malignant clone suppresses normal hematopoiesisThomas Walenda, Thomas Stiehl, Hanna Braun, et al.
International Journal of Laboratory Hematology|November 26, 2025
ICSH Recommendations for Monocyte Cell Lineage Morphologic Identification, Nomenclature Harmonization, and Utilization as a BiomarkerGina Zini, Yoon Hwan Chang, Giuseppe d'Onofrio, et al.
Clinical Epigenetics|June 19, 2012
Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acidAndrea Kuendgen, Gesine Bug, Oliver G Ottmann, et al.
Blood|June 24, 2005
Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromesAkira Matsuda, Ulrich Germing, Itsuro Jinnai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2018
Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell TransplantationChristina Rautenberg, Sabrina Pechtel, Barbara Hildebrandt, et al.
Haematologica|December 8, 2010
Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndromeMatteo G Della Porta, Luca Malcovati, Corinna Strupp, et al.
Blood Advances|September 3, 2021
Germline variants in DNA repair genes, including BRCA1/2, may cause familial myeloproliferative neoplasmsMiriam Elbracht, Robert Meyer, Kim Kricheldorf, et al.
Haematologica|June 11, 2011
Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)Luca Malcovati, Matteo G Della Porta, Corinna Strupp, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2011
Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimenChristian Saure, Thomas Schroeder, Fabian Zohren, et al.
Pageof 34

Showing results (141-150 of 339) with videos related to

Sort By:
Pageof 34
Haematologica|May 19, 2018
Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemiaStefanie Geyh, Manuel Rodríguez-Paredes, Paul Jäger, et al.
Plos Computational Biology|April 26, 2014
Feedback signals in myelodysplastic syndromes: increased self-renewal of the malignant clone suppresses normal hematopoiesisThomas Walenda, Thomas Stiehl, Hanna Braun, et al.
International Journal of Laboratory Hematology|November 26, 2025
ICSH Recommendations for Monocyte Cell Lineage Morphologic Identification, Nomenclature Harmonization, and Utilization as a BiomarkerGina Zini, Yoon Hwan Chang, Giuseppe d'Onofrio, et al.
Clinical Epigenetics|June 19, 2012
Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acidAndrea Kuendgen, Gesine Bug, Oliver G Ottmann, et al.
Blood|June 24, 2005
Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromesAkira Matsuda, Ulrich Germing, Itsuro Jinnai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2018
Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell TransplantationChristina Rautenberg, Sabrina Pechtel, Barbara Hildebrandt, et al.
Haematologica|December 8, 2010
Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndromeMatteo G Della Porta, Luca Malcovati, Corinna Strupp, et al.
Blood Advances|September 3, 2021
Germline variants in DNA repair genes, including BRCA1/2, may cause familial myeloproliferative neoplasmsMiriam Elbracht, Robert Meyer, Kim Kricheldorf, et al.
Haematologica|June 11, 2011
Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)Luca Malcovati, Matteo G Della Porta, Corinna Strupp, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2011
Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimenChristian Saure, Thomas Schroeder, Fabian Zohren, et al.
Pageof 34